Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ...

City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States and a top ...

In a study in the journal Diabetes Technology & Therapeutics (DTT), investigators evaluated biomarkers for cardiovascular ...

Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...

Tandem Diabetes Care announced today that it launched its next-generation Control-IQ+ automated insulin delivery algorithm in ...

Alnylam’s drug, vutrisiran, was approved for patients with transthyretin amyloid cardiomyopathy, or ATTR-CM, to reduce ...

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily ...

Four years into the mutually negotiated 10-year contract between Diabeter, a type 1 diabetes mellitus care-integrated ...

The FDA approved oral iptacopan (Fabhalta; Novartis) to reduce proteinuria in adults with C3 glomerulopathy (C3G), according ...

Glargine U300 use was common, especially with increased CKD stages and baseline HbA1c levels among patients with type 2 diabetes.

BeaGL was created by researchers at the University of California Davis and UC Davis Health who were inspired by their own ...

Doctors often order a blood glucose test in their clinics or at a lab to help diagnose diabetes, and people already diagnosed with diabetes might check their blood sugar levels at home to manage ...